vs
Apellis Pharmaceuticals, Inc.（APLS）与Magnolia Oil & Gas Corp（MGY）财务数据对比。点击上方公司名可切换其他公司
Magnolia Oil & Gas Corp的季度营收约是Apellis Pharmaceuticals, Inc.的1.6倍（$317.6M vs $199.9M），Magnolia Oil & Gas Corp净利率更高（21.6% vs -29.5%，领先51.1%），Magnolia Oil & Gas Corp同比增速更快（-2.7% vs -5.9%），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs -0.3%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
帝国石油是加拿大第二大一体化石油企业，由美国石油巨头埃克森美孚持有69.6%的多数股权，有时也被称为帝国埃索。公司业务涵盖原油、稀释沥青和天然气开采，同时是加拿大主要的石油炼制商与石化产品生产商，为埃索品牌加油站提供油品供应。
APLS vs MGY — 直观对比
营收规模更大
MGY
是对方的1.6倍
$199.9M
营收增速更快
MGY
高出3.2%
-5.9%
净利率更高
MGY
高出51.1%
-29.5%
两年增速更快
APLS
近两年复合增速
-0.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $317.6M |
| 净利润 | $-59.0M | $68.8M |
| 毛利率 | — | — |
| 营业利润率 | -25.6% | 29.6% |
| 净利率 | -29.5% | 21.6% |
| 营收同比 | -5.9% | -2.7% |
| 净利润同比 | -62.2% | -19.7% |
| 每股收益（稀释后） | $-0.40 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSMGY
| Q4 25 | $199.9M | $317.6M | ||
| Q3 25 | $458.6M | $324.9M | ||
| Q2 25 | $178.5M | $319.0M | ||
| Q1 25 | $166.8M | $350.3M | ||
| Q4 24 | $212.5M | $326.6M | ||
| Q3 24 | $196.8M | $333.1M | ||
| Q2 24 | $199.7M | $336.7M | ||
| Q1 24 | $172.3M | $319.4M |
净利润APLSMGY
| Q4 25 | $-59.0M | $68.8M | ||
| Q3 25 | $215.7M | $75.5M | ||
| Q2 25 | $-42.2M | $78.1M | ||
| Q1 25 | $-92.2M | $102.9M | ||
| Q4 24 | $-36.4M | $85.6M | ||
| Q3 24 | $-57.4M | $99.8M | ||
| Q2 24 | $-37.7M | $95.6M | ||
| Q1 24 | $-66.4M | $85.1M |
营业利润率APLSMGY
| Q4 25 | -25.6% | 29.6% | ||
| Q3 25 | 48.7% | 31.2% | ||
| Q2 25 | -18.6% | 33.8% | ||
| Q1 25 | -50.0% | 38.8% | ||
| Q4 24 | -12.3% | 38.0% | ||
| Q3 24 | -24.0% | 38.7% | ||
| Q2 24 | -14.7% | 39.9% | ||
| Q1 24 | -36.0% | 39.0% |
净利率APLSMGY
| Q4 25 | -29.5% | 21.6% | ||
| Q3 25 | 47.0% | 23.2% | ||
| Q2 25 | -23.6% | 24.5% | ||
| Q1 25 | -55.3% | 29.4% | ||
| Q4 24 | -17.1% | 26.2% | ||
| Q3 24 | -29.2% | 30.0% | ||
| Q2 24 | -18.9% | 28.4% | ||
| Q1 24 | -38.5% | 26.6% |
每股收益（稀释后）APLSMGY
| Q4 25 | $-0.40 | — | ||
| Q3 25 | $1.67 | — | ||
| Q2 25 | $-0.33 | — | ||
| Q1 25 | $-0.74 | — | ||
| Q4 24 | $-0.30 | — | ||
| Q3 24 | $-0.46 | — | ||
| Q2 24 | $-0.30 | — | ||
| Q1 24 | $-0.54 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $266.8M |
| 总债务越低越好 | — | $393.3M |
| 股东权益账面价值 | $370.1M | $2.0B |
| 总资产 | $1.1B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.20× |
8季度趋势，按日历期对齐
现金及短期投资APLSMGY
| Q4 25 | $466.2M | $266.8M | ||
| Q3 25 | $479.2M | $280.5M | ||
| Q2 25 | $370.0M | $251.8M | ||
| Q1 25 | $358.4M | $247.6M | ||
| Q4 24 | $411.3M | $260.0M | ||
| Q3 24 | $396.9M | $276.1M | ||
| Q2 24 | $360.1M | $275.7M | ||
| Q1 24 | $325.9M | $399.3M |
总债务APLSMGY
| Q4 25 | — | $393.3M | ||
| Q3 25 | — | $393.1M | ||
| Q2 25 | — | $392.9M | ||
| Q1 25 | — | $392.7M | ||
| Q4 24 | — | $392.5M | ||
| Q3 24 | — | $394.8M | ||
| Q2 24 | — | $394.1M | ||
| Q1 24 | $93.1M | $393.5M |
股东权益APLSMGY
| Q4 25 | $370.1M | $2.0B | ||
| Q3 25 | $401.2M | $2.0B | ||
| Q2 25 | $156.3M | $2.0B | ||
| Q1 25 | $164.2M | $2.0B | ||
| Q4 24 | $228.5M | $2.0B | ||
| Q3 24 | $237.1M | $2.0B | ||
| Q2 24 | $264.3M | $1.9B | ||
| Q1 24 | $266.7M | $1.9B |
总资产APLSMGY
| Q4 25 | $1.1B | $2.9B | ||
| Q3 25 | $1.1B | $2.9B | ||
| Q2 25 | $821.4M | $2.9B | ||
| Q1 25 | $807.3M | $2.9B | ||
| Q4 24 | $885.1M | $2.8B | ||
| Q3 24 | $901.9M | $2.8B | ||
| Q2 24 | $904.5M | $2.8B | ||
| Q1 24 | $831.9M | $2.8B |
负债/权益比APLSMGY
| Q4 25 | — | 0.20× | ||
| Q3 25 | — | 0.20× | ||
| Q2 25 | — | 0.20× | ||
| Q1 25 | — | 0.20× | ||
| Q4 24 | — | 0.20× | ||
| Q3 24 | — | 0.20× | ||
| Q2 24 | — | 0.21× | ||
| Q1 24 | 0.35× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $208.4M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | — |
| 自由现金流率自由现金流/营收 | -7.1% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | — | 3.03× |
| 过去12个月自由现金流最近4个季度 | $45.0M | — |
8季度趋势，按日历期对齐
经营现金流APLSMGY
| Q4 25 | $-14.2M | $208.4M | ||
| Q3 25 | $108.5M | $247.1M | ||
| Q2 25 | $4.4M | $198.7M | ||
| Q1 25 | $-53.4M | $224.5M | ||
| Q4 24 | $19.4M | $222.6M | ||
| Q3 24 | $34.1M | $217.9M | ||
| Q2 24 | $-8.3M | $269.4M | ||
| Q1 24 | $-133.0M | $210.9M |
自由现金流APLSMGY
| Q4 25 | $-14.3M | — | ||
| Q3 25 | $108.3M | — | ||
| Q2 25 | $4.4M | — | ||
| Q1 25 | $-53.4M | — | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-8.4M | — | ||
| Q1 24 | $-133.3M | — |
自由现金流率APLSMGY
| Q4 25 | -7.1% | — | ||
| Q3 25 | 23.6% | — | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | -32.0% | — | ||
| Q4 24 | 9.1% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -4.2% | — | ||
| Q1 24 | -77.3% | — |
资本支出强度APLSMGY
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.2% | — |
现金转化率APLSMGY
| Q4 25 | — | 3.03× | ||
| Q3 25 | 0.50× | 3.27× | ||
| Q2 25 | — | 2.54× | ||
| Q1 25 | — | 2.18× | ||
| Q4 24 | — | 2.60× | ||
| Q3 24 | — | 2.18× | ||
| Q2 24 | — | 2.82× | ||
| Q1 24 | — | 2.48× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
MGY
| Oil And Condensate | $215.6M | 68% |
| Natural Gas Reserves | $52.9M | 17% |
| Natural Gas Liquids Reserves | $49.1M | 15% |
